Spin-off news

Dewpoint Therapeutics Granted Foundational Platform Technology Patent by US Patent Office

Alnylam Presents New Results from the ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1

Proteros expands oncology collaboration and license agreement with Astrazeneca

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL

Evotec receives € 3 m milestone payment for Bayer starting Phase II clinical development of DNP programme